| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Siddharth Tiwari | Q57159156 |
| P2093 | author name string | Praveen C Verma | |
| Pradhyumna K Singh | |||
| Rakesh Tuli | |||
| P2860 | cites work | Expression of cholera toxin B subunit in transgenic tomato plants | Q78529703 |
| A functional antigen in a practical crop: LT-B producing maize protects mice against Escherichia coli heat labile enterotoxin (LT) and cholera toxin (CT) | Q78529714 | ||
| Plant molecular farming: opportunities and challenges | Q79661982 | ||
| Anti-cancer activity of plant-produced HPV16 E7 vaccine | Q79726554 | ||
| Immunogenicity of a subunit vaccine against Bacillus anthracis | Q79726566 | ||
| Ubiquitin fusion enhances cholera toxin B subunit expression in transgenic plants and the plant-expressed protein binds GM1 receptors more efficiently | Q79914068 | ||
| A new highly effective anticysticercosis vaccine expressed in transgenic papaya | Q80073173 | ||
| Oral immunogenicity of potato-derived HBsAg middle protein in BALB/c mice | Q80197599 | ||
| Mutated TATA-box/TATA binding protein complementation system for regulated transgene expression in tobacco | Q80240803 | ||
| Assessment of the utility of the tomato fruit-specific E8 promoter for driving vaccine antigen expression | Q81100769 | ||
| Mass production of somatic embryos expressing Escherichia coli heat-labile enterotoxin B subunit in Siberian ginseng | Q81240867 | ||
| Characterization of the binding of cholera toxin to ganglioside GM1 immobilized onto microtitre plates | Q81315084 | ||
| Plant based HIV-1 vaccine candidate: Tat protein produced in spinach | Q81447011 | ||
| Expression of cholera toxin B subunit and the B chain of human insulin as a fusion protein in transgenic tobacco plants | Q81563828 | ||
| Expression of cholera toxin B subunit in transgenic rice endosperm | Q81622100 | ||
| Immunogenic properties of plant-derived recombinant smallpox vaccine candidate pB5 | Q81790871 | ||
| Oral immunization with pBsVP6-transgenic alfalfa protects mice against rotavirus infection | Q81917238 | ||
| Immunological assessment of plant-derived avian flu H5/HA1 variants | Q83222891 | ||
| Development of a Genetically-Engineered, Candidate Polio Vaccine Employing the Self-Assembling Properties of the Tobacco Mosaic Virus Coat Protein | Q90744408 | ||
| Producing proteins in transgenic plants and animals | Q34365219 | ||
| Expression of hepatitis B surface antigen in transgenic banana plants | Q34421658 | ||
| Immunogenicity of transgenic plant-derived hepatitis B surface antigen | Q34437147 | ||
| Edible vaccines: current status and future | Q34639933 | ||
| Production of pharmaceutical proteins by transgenic animals | Q34744705 | ||
| Making an ally from an enemy: plant virology and the new agriculture | Q34766378 | ||
| Expression of tetanus toxin Fragment C in tobacco chloroplasts | Q34771572 | ||
| Transgenic tomatoes expressing human beta-amyloid for use as a vaccine against Alzheimer's disease | Q34792832 | ||
| A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells | Q34803801 | ||
| Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants | Q34849268 | ||
| Monoclonal antibody manufacturing in transgenic plants--myths and realities | Q35026027 | ||
| Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults | Q35047025 | ||
| Plant-based vaccines | Q35143262 | ||
| Oral immunogenicity of human papillomavirus-like particles expressed in potato | Q35182055 | ||
| Newcastle disease vaccines | Q35555244 | ||
| cDNA cloning of the complete genome of tobacco mosaic virus and production of infectious transcripts | Q35595490 | ||
| Plant production systems for vaccines | Q35623378 | ||
| Plant-based production of biopharmaceuticals | Q35683387 | ||
| Smallpox subunit vaccine produced in Planta confers protection in mice | Q35800424 | ||
| Production of human papillomavirus type 16 virus-like particles in transgenic plants | Q35802720 | ||
| Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination | Q35865115 | ||
| Immunization against rabies with plant-derived antigen | Q35922495 | ||
| Modification of plant N-glycans processing: the future of producing therapeutic protein by transgenic plants | Q35925258 | ||
| Plant cell cultures for the production of recombinant proteins | Q35940957 | ||
| Fruit-specific expression of the human immunodeficiency virus type 1 tat gene in tomato plants and its immunogenic potential in mice. | Q35946931 | ||
| Plant-derived vaccines and antibodies: potential and limitations | Q36055946 | ||
| Vaccines and sera through plant biotechnology | Q36055951 | ||
| Cowpea mosaic virus-based systems for the production of antigens and antibodies in plants | Q36055974 | ||
| The development of a plant-based vaccine for measles | Q36056008 | ||
| Plant-derived vaccines against diarrheal diseases | Q36056011 | ||
| Sowing the seeds of success: pharmaceutical proteins from plants. | Q36098498 | ||
| Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. | Q36158822 | ||
| Plant-derived pharmaceuticals--the road forward | Q36313817 | ||
| Expression of Bacillus anthracis protective antigen in transgenic chloroplasts of tobacco, a non-food/feed crop | Q36349402 | ||
| Protective immunity against murine hepatitis virus (MHV) induced by intranasal or subcutaneous administration of hybrids of tobacco mosaic virus that carries an MHV epitope | Q36405100 | ||
| Review: Genetically modified plants for the promotion of human health | Q36642207 | ||
| Production of hepatitis B surface antigen in recombinant plant systems: an update | Q36755687 | ||
| Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview | Q36792657 | ||
| Effective plague vaccination via oral delivery of plant cells expressing F1-V antigens in chloroplasts. | Q36804213 | ||
| Presentation of a foreign peptide on the surface of tomato bushy stunt virus | Q36866662 | ||
| Comparison of the carbohydrate-binding specificities of cholera toxin and Escherichia coli heat-labile enterotoxins LTh-I, LT-IIa, and LT-IIb | Q36997416 | ||
| Beyond risk. A more realistic risk-benefit analysis of agricultural biotechnologies | Q37124469 | ||
| Preventing unintended proteolysis in plant protein biofactories | Q37152888 | ||
| Recent progress in the development of plant derived vaccines | Q37290098 | ||
| Expression of hepatitis B surface antigen in transgenic plants | Q37337644 | ||
| New horizons in adjuvants for vaccine development | Q37342049 | ||
| Mechanism of action of clinically approved adjuvants | Q37402088 | ||
| Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice | Q37584470 | ||
| Expression of synthetic neutralizing epitope of porcine epidemic diarrhea virus fused with synthetic B subunit of Escherichia coli heat-labile enterotoxin in tobacco plants | Q38320811 | ||
| Synthesis and assembly of anthrax lethal factor-cholera toxin B-subunit fusion protein in transgenic potato | Q38334315 | ||
| Assembly of cholera toxin B subunit full-length rotavirus NSP4 fusion protein oligomers in transgenic potato | Q38353887 | ||
| Role of membrane gangliosides in the binding and action of bacterial toxins. | Q38355804 | ||
| Cholera toxin B protein in transgenic tomato fruit induces systemic immune response in mice | Q39106728 | ||
| Protective immune response to foot-and-mouth disease virus with VP1 expressed in transgenic plants. | Q39642504 | ||
| Production of recombinant HIV-1/HBV virus-like particles in Nicotiana tabacum and Arabidopsis thaliana plants for a bivalent plant-based vaccine | Q40058510 | ||
| Secretion of hepatitis B surface antigen in transformed tobacco cell suspension cultures | Q40386799 | ||
| Expression of single-chain antibodies in transgenic plants. | Q40454035 | ||
| Expression of the B subunit of Escherichia coli heat-labile enterotoxin as a fusion protein in transgenic tomato. | Q40577761 | ||
| Expression of protective antigen in transgenic plants: a step towards edible vaccine against anthrax. | Q40688200 | ||
| Hepatitis B surface antigen (HBsAg) expression in plant cell culture: Kinetics of antigen accumulation in batch culture and its intracellular form | Q40694013 | ||
| Plant-derived human papillomavirus 16 E7 oncoprotein induces immune response and specific tumor protection | Q40720881 | ||
| Plants as biofactories for the production of subunit vaccines against bio-security-related bacteria and viruses. | Q41438807 | ||
| P19-dependent and P19-independent reversion of F1-V gene silencing in tomato | Q41443410 | ||
| A plant-produced plague vaccine candidate confers protection to monkeys | Q41450225 | ||
| Plant-made subunit vaccine against pneumonic and bubonic plague is orally immunogenic in mice | Q41455267 | ||
| Oral immunization of animals with transgenic cherry tomatillo expressing HBsAg | Q41886182 | ||
| Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts | Q41947780 | ||
| In planta expression of HIV-1 p24 protein using an RNA plant virus-based expression vector | Q42628835 | ||
| Expression of the human hepatitis B virus large surface antigen gene in transgenic tomato plants | Q42800873 | ||
| Development of a plant-derived subunit vaccine candidate against hepatitis C virus | Q43029906 | ||
| Expression of recombinant human acetylcholinesterase in transgenic tomato plants. | Q43759333 | ||
| High-level expression of the neutralizing epitope of porcine epidemic diarrhea virus by a tobacco mosaic virus-based vector | Q43959421 | ||
| Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus | Q43963260 | ||
| Factors important in the extraction, stability and in vitro assembly of the hepatitis B surface antigen derived from recombinant plant systems | Q44019328 | ||
| Molecular farming for new drugs and vaccines. Current perspectives on the production of pharmaceuticals in transgenic plants | Q24539099 | ||
| Retracted: An enhanced transient expression system in plants based on suppression of gene silencing by the p19 protein of tomato bushy stunt virus | Q29037949 | ||
| Magnifection--a new platform for expressing recombinant vaccines in plants | Q30320267 | ||
| Immunogenicity of hemagglutinin from A/Bar-headed Goose/Qinghai/1A/05 and A/Anhui/1/05 strains of H5N1 influenza viruses produced in Nicotiana benthamiana plants. | Q30374793 | ||
| Intranasal immunization with a plant virus expressing a peptide from HIV-1 gp41 stimulates better mucosal and systemic HIV-1-specific IgA and IgG than oral immunization | Q30432136 | ||
| Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica A1 leukotoxin 50 fusion protein | Q31000665 | ||
| Accumulation of recombinant SARS-CoV spike protein in plant cytosol and chloroplasts indicate potential for development of plant-derived oral vaccines | Q33256026 | ||
| Expression of HPV-11 L1 protein in transgenic Arabidopsis thaliana and Nicotiana tabacum | Q33298684 | ||
| Expression of HIV-1 antigens in plants as potential subunit vaccines | Q33345905 | ||
| Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice. | Q33640085 | ||
| Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus | Q33648566 | ||
| Chimeric plant virus particles as immunogens for inducing murine and human immune responses against human immunodeficiency virus type 1. | Q33854138 | ||
| Immunogenicity in humans of an edible vaccine for hepatitis B. | Q33858661 | ||
| Induction of a virus-specific antibody response to foot and mouth disease virus using the structural protein VP1 expressed in transgenic potato plants | Q33939758 | ||
| Oral immunization with hepatitis B surface antigen expressed in transgenic plants | Q33944696 | ||
| Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene | Q34067072 | ||
| Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge | Q34194628 | ||
| Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants | Q34240349 | ||
| Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system | Q34250117 | ||
| The production of recombinant pharmaceutical proteins in plants. | Q34267406 | ||
| Successful boosting of a DNA measles immunization with an oral plant-derived measles virus vaccine | Q34343918 | ||
| Gangliosides and membrane receptors for cholera toxin | Q47972854 | ||
| The binding potential between the cholera toxin B-oligomer and its receptor | Q47984324 | ||
| Development of an antigen presentation system based on plum pox potyvirus | Q48025754 | ||
| Boosting heterologous protein production in transgenic dicotyledonous seeds using Phaseolus vulgaris regulatory sequences | Q49038822 | ||
| Conformational analysis of hepatitis B surface antigen fusions in an Agrobacterium-mediated transient expression system. | Q50705974 | ||
| High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. | Q50705983 | ||
| Superexpression of tuberculosis antigens in plant leaves. | Q51092359 | ||
| An important date in rabies history. | Q51110404 | ||
| Cosecretion of protease inhibitor stabilizes antibodies produced by plant roots. | Q51149596 | ||
| Creation and analysis of a novel chimeric promoter for the complete containment of pollen- and seed-mediated gene flow. | Q51712158 | ||
| A quick and efficient system for antibiotic-free expression of heterologous genes in tobacco roots. | Q51713359 | ||
| Effect of climate conditions and plant developmental stage on the stability of antibodies expressed in transgenic tobacco. | Q52165355 | ||
| Integration and expression of Bluetongue VP2 gene in somatic embryos of peanut through particle bombardment method. | Q52841013 | ||
| Immunogenicity of peptides derived from a fibronectin-binding protein of S. aureus expressed on two different plant viruses. | Q52911680 | ||
| Characterization of the immune response to canine parvovirus induced by vaccination with chimaeric plant viruses. | Q52939975 | ||
| Transgenic tomatoes express an antigenic polypeptide containing epitopes of the diphtheria, pertussis and tetanus exotoxins, encoded by a synthetic gene. | Q53542058 | ||
| Cognitive processes and the decisions of some parents to forego pertussis vaccination for their children. | Q53623002 | ||
| The green revolution: plants as heterologous expression vectors. | Q54015884 | ||
| Expression of cholera toxin B subunit oligomers in transgenic potato plants. | Q54150448 | ||
| Development and evaluation of transgenic rice seeds accumulating a type II-collagen tolerogenic peptide. | Q54420835 | ||
| Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). | Q54432136 | ||
| Ingestion of transgenic carrots expressing the Escherichia coli heat-labile enterotoxin B subunit protects mice against cholera toxin challenge. | Q54434314 | ||
| Production of Escherichia coli heat labile toxin (LT) B subunit in soybean seed and analysis of its immunogenicity as an oral vaccine. | Q54449589 | ||
| Production of a fusion protein consisting of the enterotoxigenic Escherichia coli heat-labile toxin B subunit and a tuberculosis antigen in Arabidopsis thaliana. | Q54517140 | ||
| Delivery of subunit vaccines in maize seed. | Q54533764 | ||
| Oral immunization with a recombinant bacterial antigen produced in transgenic plants. | Q54612499 | ||
| Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. | Q54696665 | ||
| Phytosecretion of enteropathogenic Escherichia coli pilin subunit A in transgenic tobacco and its suitability for early life vaccinology | Q56762901 | ||
| Production of hepatitis B surface antigen in transgenic plants for oral immunization | Q57235165 | ||
| Effects of ganglioside GM1 on the thermotropic behavior of cholera toxin B subunit | Q70655048 | ||
| Enhanced recovery of a secreted mammalian protein from suspension culture of genetically modified tobacco cells | Q71545095 | ||
| Oral immunogenicity of the plant derived spike protein from swine-transmissible gastroenteritis coronavirus | Q72996388 | ||
| Plant-derived vaccine protects target animals against a viral disease | Q73137252 | ||
| Polypeptides of hepatitis B surface antigen produced in transgenic potato | Q73421178 | ||
| Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies | Q73507054 | ||
| Rhizosecretion of recombinant proteins from plant hairy roots | Q73559001 | ||
| Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection | Q73572386 | ||
| Plant-based vaccines: unique advantages | Q73636886 | ||
| Oral immunisation of naive and primed animals with transgenic potato tubers expressing LT-B | Q73636896 | ||
| Rotavirus VP6 expressed by PVX vectors in Nicotiana benthamiana coats PVX rods and also assembles into viruslike particles | Q73740042 | ||
| Oral immunization with rotavirus VP7 expressed in transgenic potatoes induced high titers of mucosal neutralizing IgA | Q73897782 | ||
| Processing and localization of bovine beta-casein expressed in transgenic soybean seeds under control of a soybean lectin expression cassette | Q74185485 | ||
| Production and purification of two recombinant proteins from transgenic corn | Q74297314 | ||
| Efficacy of a food plant-based oral cholera toxin B subunit vaccine | Q74401546 | ||
| Production of immunogenic VP6 protein of bovine group A rotavirus in transgenic potato plants | Q74446677 | ||
| Deposition of storage proteins | Q77304424 | ||
| Expression of immunogenic glycoprotein S polypeptides from transmissible gastroenteritis coronavirus in transgenic plants | Q77472394 | ||
| Development of biopharmaceuticals in plant expression systems: cloning, expression and immunological reactivity of human cytomegalovirus glycoprotein B (UL55) in seeds of transgenic tobacco | Q78171079 | ||
| Studies on the immunogenic potential of plant-expressed cholera toxin B subunit | Q44065882 | ||
| Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine | Q44183728 | ||
| Immunogenicity of a novel, bivalent, plant-based oral vaccine against hepatitis B and human immunodeficiency viruses | Q44280479 | ||
| Peptide-based candidate vaccine against respiratory syncytial virus | Q44355444 | ||
| Protection of rabbits against rabbit hemorrhagic disease virus by immunization with the VP60 protein expressed in plants with a potyvirus-based vector | Q44440973 | ||
| High-yield expression of a viral peptide vaccine in transgenic plants | Q44911177 | ||
| Immunogenicity of a plant-derived edible rotavirus subunit vaccine transformed over fifty generations | Q45065706 | ||
| Expression of an Escherichia coli antigenic fusion protein comprising the heat labile toxin B subunit and the heat stable toxin, and its assembly as a functional oligomer in transplastomic tobacco plants | Q45165212 | ||
| Analysis of receptor-binding site in Escherichia coli enterotoxin | Q45202248 | ||
| Biosynthesis, processing and targeting of the G-protein of vesicular stomatitis virus in tobacco protoplasts | Q45349120 | ||
| Expression of the rabies virus nucleoprotein in plants at high-levels and evaluation of immune responses in mice. | Q45397168 | ||
| Immunogenicity of recombinant hepatitis B virus surface antigen fused with preS1 epitopes expressed in rice seeds | Q45399996 | ||
| Expression of the fusion glycoprotein of Newcastle disease virus in transgenic rice and its immunogenicity in mice | Q45410974 | ||
| Expression of tuberculosis antigen ESAT-6 in Nicotiana tabacum using a potato virus X-based vector. | Q45417242 | ||
| High level expression of surface glycoprotein of rabies virus in tobacco leaves and its immunoprotective activity in mice. | Q45433520 | ||
| Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses | Q45507304 | ||
| A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine | Q45628295 | ||
| Oral immunization of cattle with hemagglutinin protein of rinderpest virus expressed in transgenic peanut induces specific immune responses | Q45722956 | ||
| Neutralizing immunogenicity of transgenic carrot (Daucus carota L.)-derived measles virus hemagglutinin | Q45728664 | ||
| Oral immunization using tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus capsid protein. | Q45728666 | ||
| A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. | Q45734020 | ||
| Inactivated recombinant plant virus protects dogs from a lethal challenge with canine parvovirus | Q45737037 | ||
| Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. | Q45738399 | ||
| Human respiratory syncytial virus vaccine antigen produced in plants | Q45740005 | ||
| Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response | Q45740945 | ||
| Human immune responses to a novel norwalk virus vaccine delivered in transgenic potatoes | Q45741675 | ||
| Immunization with a chimeric tobacco mosaic virus containing an epitope of outer membrane protein F of Pseudomonas aeruginosa provides protection against challenge with P. aeruginosa | Q45743834 | ||
| Immunogenicity of porcine transmissible gastroenteritis virus spike protein expressed in plants | Q45744006 | ||
| Rapid production of single-chain Fv fragments in plants using a potato virus X episomal vector | Q45744873 | ||
| Protection of mice against challenge with foot and mouth disease virus (FMDV) by immunization with foliar extracts from plants infected with recombinant tobacco mosaic virus expressing the FMDV structural protein VP1. | Q45746533 | ||
| A plant-derived edible vaccine against hepatitis B virus. | Q45746962 | ||
| A chimaeric plant virus vaccine protects mice against a bacterial infection | Q45747597 | ||
| Pseudomonas aeruginosa outer-membrane protein F epitopes are highly immunogenic in mice when expressed on a plant virus | Q45750008 | ||
| Analysis of the ability of five adjuvants to enhance immune responses to a chimeric plant virus displaying an HIV-1 peptide. | Q45750179 | ||
| Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunization with alfalfa transgenic plants expressing the viral structural protein VP1. | Q45750862 | ||
| Expression of the rabies virus glycoprotein in transgenic tomatoes | Q45755402 | ||
| Stimulation of neutralizing antibodies to human immunodeficiency virus type 1 in three strains of mice immunized with a 22 amino acid peptide of gp41 expressed on the surface of a plant virus | Q45768056 | ||
| Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides | Q45781264 | ||
| A new tobacco mosaic virus vector and its use for the systemic production of angiotensin-I-converting enzyme inhibitor in transgenic tobacco and tomato | Q45785478 | ||
| Expression of an Animal Virus Antigenic Site on the Surface of a Plant Virus Particle | Q45786671 | ||
| Systemic production of foreign peptides on the particle surface of tobacco mosaic virus | Q45789411 | ||
| Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response | Q45790419 | ||
| A plant-based multicomponent vaccine protects mice from enteric diseases | Q45877640 | ||
| A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes | Q45889680 | ||
| Transformation of an edible crop with the pagA gene of Bacillus anthracis | Q46609272 | ||
| Expression of cholera toxin subunits in plants | Q46682172 | ||
| Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants | Q47289067 | ||
| Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato | Q47614578 | ||
| Process and economic evaluation of the extraction and purification of recombinant beta-glucuronidase from transgenic corn | Q47725493 | ||
| Expression of the hepatitis B surface S and preS2 antigens in tubers of Solanum tuberosum | Q47868380 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bioreactor | Q864699 |
| vaccine | Q134808 | ||
| P304 | page(s) | 449-467 | |
| P577 | publication date | 2009-04-06 | |
| P1433 | published in | Biotechnology Advances | Q4915328 |
| P1476 | title | Plants as bioreactors for the production of vaccine antigens | |
| P478 | volume | 27 |
| Q42148218 | A transgenic plant cell-suspension system for expression of epitopes on chimeric Bamboo mosaic virus particles |
| Q38285425 | Advances and challenges in the development and production of effective plant-based influenza vaccines |
| Q38480716 | Antibody Responses in Mice Stimulated by Various Doses of the Potato-Derived Major Surface Antigen of Hepatitis B Virus |
| Q37859086 | Chloroplast-derived vaccines against human diseases: achievements, challenges and scopes. |
| Q39204136 | Corn-based vaccines: current status and prospects. |
| Q43792763 | Cucumber mosaic virus as the expression system for a potential vaccine against Alzheimer's disease |
| Q91970026 | Development of a Transgenic Flammulina velutipes Oral Vaccine for Hepatitis B |
| Q30234320 | Disease Prevention: An Opportunity to Expand Edible Plant-Based Vaccines? |
| Q42987866 | Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants |
| Q40422774 | Engineering and expression of a RhoA peptide against respiratory syncytial virus infection in plants. |
| Q45361337 | Enhanced expression of rabies virus surface G-protein in Escherichia coli using SUMO fusion |
| Q42278268 | Expression and assembly of Norwalk virus-like particles in plants using a viral RNA silencing suppressor gene |
| Q47229938 | Expression of Human Immunodeficiency Virus type 1 (HIV-1) coat protein genes in plants using cotton leaf curl Multan betasatellite-based vector. |
| Q35625893 | Expression of enterovirus 71 virus-like particles in transgenic enoki (Flammulina velutipes). |
| Q39658904 | Expression of human apolipoprotein A-I in Nicotiana tabacum |
| Q40894293 | Expression of recombinant staphylokinase, a fibrin-specific plasminogen activator of bacterial origin, in potato (Solanum tuberosum L.) plants |
| Q83396893 | Genetic engineering of a Lemna isoleucine auxotroph |
| Q40217465 | Good manufacturing practices production of a purification-free oral cholera vaccine expressed in transgenic rice plants |
| Q84701000 | High level expression of a functionally active cholera toxin B: rabies glycoprotein fusion protein in tobacco seeds |
| Q82416184 | Immunogenicity of recombinant GP5 protein of porcine reproductive and respiratory syndrome virus expressed in tobacco plant |
| Q54285024 | Improved expression of recombinant plant-made hEGF. |
| Q40719670 | Induction of a dwarf phenotype with IBH1 may enable increased production of plant-made pharmaceuticals in plant factory conditions |
| Q45356467 | Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein |
| Q38174581 | Molecular farming of human cytokines and blood products from plants: challenges in biosynthesis and detection of plant-produced recombinant proteins |
| Q30252148 | Molecular farming on rescue of pharma industry for next generations. |
| Q58592521 | Neuroticism and Somatic Complaints: Concomitant Effects of Rumination and Worry |
| Q35002326 | On the way to commercializing plant cell culture platform for biopharmaceuticals: present status and prospect |
| Q38778390 | Oral Rabies Vaccine Design for Expression in Plants. |
| Q53280172 | Oral immunogenicity of tomato-derived sDPT polypeptide containing Corynebacterium diphtheriae, Bordetella pertussis and Clostridium tetani exotoxin epitopes. |
| Q38036581 | Overview of plant-made vaccine antigens against malaria |
| Q33942011 | Plant Hsp90 proteins interact with B-cells and stimulate their proliferation |
| Q39603076 | Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans |
| Q37776722 | Plant-based vaccines against human hepatitis B virus |
| Q38121856 | Plant-derived pharmaceuticals for the developing world |
| Q37776718 | Plant-derived vaccines and other therapeutics produced in contained systems |
| Q37983418 | Plant-derived vaccines: an approach for affordable vaccines against cervical cancer |
| Q30386732 | Plant-made vaccines for humans and animals. |
| Q26783107 | Plant-produced candidate countermeasures against emerging and reemerging infections and bioterror agents |
| Q34018403 | Plants as bioreactors: Recent developments and emerging opportunities |
| Q42204036 | Presentation of epitope sequences from foreign viruses on the surface of apple latent spherical virus particles |
| Q36555514 | Production of Human papillomavirus pseudovirions in plants and their use in pseudovirion-based neutralisation assays in mammalian cells |
| Q43743537 | Prophylactic effect of the oral administration of transgenic rice seeds containing altered peptide ligands of type II collagen on rheumatoid arthritis. |
| Q30151541 | Purification and immunogenicity of hemagglutinin from highly pathogenic avian influenza virus H5N1 expressed in Nicotiana benthamiana |
| Q38261152 | Recent developments in therapeutic protein expression technologies in plants. |
| Q38534952 | Rice seed for delivery of vaccines to gut mucosal immune tissues |
| Q36258430 | Stability and pre-formulation development of a plant-produced anthrax vaccine candidate |
| Q36327788 | Stable plastid transformation for high-level recombinant protein expression: promises and challenges. |
| Q90668573 | State of research in the field of the creation of plant vaccines for veterinary use |
| Q37812659 | Strategies for the plant‐based expression of dengue subunit vaccines |
| Q28073401 | The Last Ten Years of Advancements in Plant-Derived Recombinant Vaccines against Hepatitis B |
| Q54227034 | The modified rice αAmy8 promoter confers high-level foreign gene expression in a novel hypoxia-inducible expression system in transgenic rice seedlings. |
| Q39792117 | The potential impact of plant biotechnology on the Millennium Development Goals |
| Q36590168 | The twenty-year story of a plant-based vaccine against hepatitis B: stagnation or promising prospects? |
| Q37744913 | Transgenic plant-based oral vaccines |
| Q36888054 | Transgenic tobacco expressed HPV16-L1 and LT-B combined immunization induces strong mucosal and systemic immune responses in mice |
Search more.